CFD
ALNY icon

Creative Financial Designs’s Alnylam Pharmaceuticals ALNY Stock Holding History

Creative Financial Designs’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301 Hold
1
– – ﹤0.01% 2179
2026
Q1 		$331 Sell
1
-1
-50% -$340 ﹤0.01% 2039
2025
Q4 		$795 Hold
2
– – ﹤0.01% 1837
2025
Q3 		$912 Buy
2
+1
+100% +$407 ﹤0.01% 1823
2025
Q2 		$326 Hold
1
– – ﹤0.01% 1915
2025
Q1 		$270 Buy
+1
New +$257 ﹤0.01% 1961

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Financial Designs's ALNY Position: Q2 2026 in Review

Creative Financial Designs held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 1 share worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #2179.

Creative Financial Designs first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $912 in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Creative Financial Designs held 1 share of Alnylam Pharmaceuticals worth $301 as of Q2 2026.
  • Creative Financial Designs left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #2179 holding.
  • Creative Financial Designs first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Creative Financial Designs's Alnylam Pharmaceuticals position peaked at $912 in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.